By the end of this Webinar, the participants will be able to:
- Understand the global disease burden related to venous thromboembolism;
- Apply evidence-based, risk-adjusted algorithms to diagnose or exclude clinically suspected pulmonary embolism;
- Understand the importance of assessing “pre-test” probability of pulmonary embolism and the utility of age-adjusted D-dimer cutoffs;
- Distinguish between intermediate-high, intermediate-low, and low-risk pulmonary embolism, and apply this knowledge in the acute-phase management;
- Understand the modalities, benefits, and caveats of early reperfusion therapy (systemic thrombolysis, surgical or catheter-directed treatment);
- Decide on the use vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants (NOACs) in the treatment and secondary prophylaxis;
- Treat venous thromboembolism during pregnancy;
- Make a state-of-the-art triage of patients who may be candidates for extended or indefinite anticoagulation after PE;
- Identify patients prone to develop chronic thromboembolic pulmonary hypertension after pulmonary embolism.
General cardiology webinars on-demand are now exclusively CME accredited for ESC Professional & Professional Plus Members.